IDO1 and non-small cell lung carcinoma: To clarify the molecular mechanisms at the basis of IDO1 overexpression in multidrug resistant cells, we focused on the model of non small cell lung cancer A549 and A549/dx cells, where the difference of IDO1 expression between sensitive and resistant cells was particularly pronounced.